2Wtanabe H,stanada H,shigetomi S,et al. Urinary excretion of type IV collagenas a specific in dicator of the progression of diabetic nephropathy.Nephrol,2000,(86):27-35.
3Park IS ,Kiyomoto H,Annoud SL,et al. Expression of transforming growth factor β and IV collagen in early streptozocin induced diabetes.Diabetes,1997,46:924.
5Okongi H,Nishimura M,Utsunomiya Y,et al. Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin Nephrol,2001,55:357-364.
6Cohen MP, Ziyadeh FN, Lautenslager GT,et al. Glycated albumins stimulation of PKC-beta activity is linked to increased collagen IV in measangial cells. Am J Physiol,1999,276:684-690.
9Sassy Prigent C,Heudes D,Mandet C, et al. Early glomerular macrophage cruitment in streptozotoicin induced diabetic rats.Diabetes,2000,49:466-475.
10Chen S, Cohen MP,Lautens larger GT, et al. Glycated albumin stimulates TGF beta1 production and prote in kinase C activity in glomeruia rendo the lial cellks.Kidney Int,2001,59:673-681.
3[7]Ketteler M, Noble NA, Border WA. Transforming growth factor-β and angiotensin Ⅱ: the missing link from glornerular hyperfiltration to glomerulosclerosis. Annu Rev Physiol,1995,57: 279-295.
4[8]Miller JA. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol, 1999,10:1778-1785.
5[9]Price DA, Porter LE, Gordon M, et al. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol,1999,10: 2382-2391.
6[10]Gleizes, PE, Munger JS, Nunes I, et al. TGF-latency: biological significance and mechanisms of activation. Stem Cells, 1997,15:190-197.
7[11]Lane P. Diabetic kidney disease: impact of puberty. Am J Physiol Renal Physiol, 2002,283: F589-F600.
8[12]Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.Pharmacol Rev, 1998,50: 21-33.
9[13]Miller JA, Floras JS, Zinman B, et al. Abnormalities in the renal and vascular responses to LBNP in humans with early diabetes. Am J Physiol, 1994,266: R442-R450.
10Lupia E, Elliot S J, Lenz O.IGF-1 decreases collagen degrad ation in diabetic NOD mesangial cells: implications for diabetic nephropathy[J ].Diabetes,1999,48:1638-1644.
5Dronavalli S,Duka I,Bakris G L.The pathogenesis of diabetic nephropathy[J].J Nat Clin Pract Endorinal Metab,2008,4(8):444-452.
6Nakayama S,Watada H.The impact of strict glycemic control on diabetic microangiopathy[J].Nihon Rinsho,2010,68(9):131-135.
7Singh V P,Bali A,Singh N,et al.Advanced glycation end products and diabetic complications[J].Korean J Physiol Pharmacol,2014,18(1):1-14.
8Monnier L,Mas E,Ginet C,et al.Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes[J].JAMA,2006,95(14):1681-1687.
